Eric Lenze
Washington University School of Medicine · Washington University School of Medicine, Department of Psychiatry · Washington University School of Medicine, St. Louis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Lenze as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07000734 · Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot StudyWashington University School of Medicine · completed · Aging, Cognitive Decline, Older Adults · principal investigator
- Ph2/Ph3NCT05874037 · Fluvoxamine for Long COVID-19Washington University School of Medicine · completed · Long COVID · principal investigator
- Ph2NCT05838560 · Dasatinib Plus Quercetin for Accelerated Aging in Mental DisordersWashington University School of Medicine · active not recruiting · Schizophrenia, Treatment Resistant Depression, Aging, Premature · principal investigator
- N/ANCT05393622 · Brain Stimulation for Severe DepressionInner Cosmos Inc · recruiting · Depression Severe · principal investigator
- Ph4NCT04504175 · Ketamine for Older Adults PilotWashington University School of Medicine · completed · Treatment Resistant Depression, Refractory Depression, Therapy-Resistant Depression · principal investigator
- Ph4NCT03272711 · Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive TrainingWashington University School of Medicine · completed · Age-related Cognitive Decline · principal investigator
- Ph4NCT02960763 · Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsWashington University School of Medicine · completed · Treatment Resistant Depression, Major Depressive Disorder, Treatment-Refractory Depression · principal investigator
- N/ANCT02241655 · Electroencephalography Guidance of AnesthesiaWashington University School of Medicine · completed · Delirium · study director
- N/ANCT02114879 · Enhanced Medical Rehabilitation in Older AdultsWashington University School of Medicine · completed · Disabling Medical Events, Disabled, Depression · principal investigator
- Ph1/Ph2NCT01693874 · Mindfulness-based Stress Reduction and Cognitive Function in Stress and AgingWashington University School of Medicine · completed · Anxiety Disorders, Depression · principal investigator
- N/ANCT01179009 · Treatment Resistant Depression (Pilot)Washington University School of Medicine · completed · Depressive Disorder, Treatment-Resistant · principal investigator
- Ph4NCT00892047 · Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)University of Pittsburgh · completed · Depression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)UH3MH137353 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2026 · $529,185 awarded in 2026Same name and institution; not confirmed by an ID
- Center for Perioperative Mental HealthP50MH122351 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2021 to 2026 · $2,332,500 awarded in 2026Same name and institution; not confirmed by an ID
- Resilience and brain health of older adultsR01AG072694 · NIA · WASHINGTON UNIVERSITY · fiscal years 2021 to 2025 · $1,802,239 awarded in 2025Same name and institution; not confirmed by an ID
- Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) TrialU01MH128483 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2022 to 2025 · $699,647 awarded in 2025Same name and institution; not confirmed by an ID
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)UG3MH137353 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2024 · $1,370,657 awarded in 2024Same name and institution; not confirmed by an ID
- Remediating Age Related-Cognitive Decline: Mindfulness-Based Stress Reduction and ExerciseR01AG049369 · NIA · WASHINGTON UNIVERSITY · fiscal years 2014 to 2019 · $359,654 awarded in 2019Same name and institution; not confirmed by an ID
- ENHANCED MEDICAL REHABILITATION FOR OLDER ADULTSR01MH099011 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2013 to 2017 · $527,217 awarded in 2017Grant number is on one of their registry trials
- 2/3 BUPRENORPHINE FOR TREATMENT-RESISTANT LATE-LIFE DEPRESSIONR34MH101433 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2014 to 2016 · $369,282 awarded in 2016Same name and institution; not confirmed by an ID
- 2/3-Incomplete Response in Late-Life Depression: Getting to RemissionR01MH083648 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2009 to 2013 · $373,699 awarded in 2013Same name and institution; not confirmed by an ID
- MINDFULNESS- BASED STRESS REDUCTION AND COGNITIVE FUNCTION IN STRESS AND AGINGR34AT007064 · NCCIH · WASHINGTON UNIVERSITY · fiscal years 2011 to 2013 · $214,569 awarded in 2013Same name and institution; not confirmed by an ID
- Risk Genes for Late-Life Depression after Hip FractureR01MH074596 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2007 to 2011 · $373,702 awarded in 2011Same name and institution; not confirmed by an ID
- Enhanced Medical Rehabilitation for Late-Life Depression After DisablementR34MH083868 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2009 to 2010 · $336,896 awarded in 2010Same name and institution; not confirmed by an ID
- Pharmacotherapy of Latelife Generalized Anxiety DisorderR01MH070547 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2005 to 2009 · $295,455 awarded in 2009Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Electroencephalograph Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENUH2AG050312 · NIA · WASHINGTON UNIVERSITY · PI Michael Simon Avidan · fiscal years 2014Named on NCT02241655
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:46 UTC. The ranking covers the 200 most relevant of 109 PubMed records, and a shared surname and initials can bring in a namesake. All 109 on PubMed
- 408 citationsRCR 19.8
- 385 citationsRCR 25.3
- Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.Lancet Glob Health · 2022307 citationsRCR 21.7
- Maintenance treatment of major depression in old age.N Engl J Med · 2006288 citationsRCR 9.0
- 212 citationsRCR 9.3
- Ecological momentary assessment versus standard assessment instruments for measuring mindfulness, depressed mood, and anxiety among older adults.J Psychiatr Res · 2016188 citationsRCR 10.3
- Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.J Clin Psychiatry · 2014157 citationsRCR 6.4
- Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study.Br J Psychiatry · 2007142 citationsRCR 4.7
- 132 citationsRCR 11.1
- Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.Arch Gen Psychiatry · 2011131 citationsRCR 4.7